P001 Cystic fibrosis newborn screening (CF-NBS) start-up in Flanders (Belgium): report of first evaluation after 3 years

MLA

M. Proesmans, et al. “P001 Cystic Fibrosis Newborn Screening (CF-NBS) Start-up in Flanders (Belgium): Report of First Evaluation after 3 Years.” Journal of Cystic Fibrosis, vol. 21, June 2022, p. S61. EBSCOhost, https://doi.org/10.1016/s1569-1993(22)00337-x.

APA

M. Proesmans, L. Regal, F. Eyskens, L. Roosens, L. Marcelis, S. Seneca, K. Storm, K. Colaert, & E. De Wachter. (2022). P001 Cystic fibrosis newborn screening (CF-NBS) start-up in Flanders (Belgium): report of first evaluation after 3 years. Journal of Cystic Fibrosis, 21, S61. https://doi.org/10.1016/s1569-1993(22)00337-x

Chicago

M. Proesmans, L. Regal, F. Eyskens, L. Roosens, L. Marcelis, S. Seneca, K. Storm, K. Colaert, and E. De Wachter. 2022. “P001 Cystic Fibrosis Newborn Screening (CF-NBS) Start-up in Flanders (Belgium): Report of First Evaluation after 3 Years.” Journal of Cystic Fibrosis 21 (June): S61. doi:10.1016/s1569-1993(22)00337-x.